Filter posts

IPAB: Bad Medicine for Patient Care

The Independent Payment Advisory Board is bad medicine for patient care, deficit reduction and containing …

Young Invincibles Still Need Flu Shot

Last Friday, the CDC reported that 35 states are seeing widespread cases of influenza. Young …

Couldn’t Make it to San Francisco This Week?

Me neither, so here is what I am reading for updates about the 32nd Annual JPMorgan Healthcare …

BIO Joins Partners for Healthy Dialogues

The Biotechnology Industry Organization (BIO) recently joined the Partners for Healthy Dialogues effort. Dialogues+ had …

National Traceability System Moves into Implementation

Last week, President Obama signed into law the Drug Quality and Security Act (H.R. 3204), …

The Arrival of Actionable Personalized Medicine

The pace of implementation of next-generation sequencing (NGS) in a clinical context, which almost rivals …

A Manhattan Project for Alzheimer's Disease

Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & …

Bridging Research to Cures: Summit for R&D Companies

As human and animal health companies struggle to advance medical innovation while managing costs, the …

BIO Patient and Health Advocacy Summit: Patient-Focused Drug Development

Panelists in this morning’s opening session outlined strategies for the FDA to better engage the …

Uniting To Accelerate Pediatric Medicine

Drug companies inherently absorb significant risk when developing compounds and biologics for clinical use. A …